Reneo Pharmaceuticals Stock (NASDAQ: RPHM) stock price, news, charts, stock research, profile.
Open | $1.780 |
Close | $1.760 |
Volume / Avg. | 76.424K / 239.335K |
Day Range | 1.700 - 1.780 |
52 Wk Range | 0.980 - 11.295 |
Market Cap | $58.821M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 14.55% |
Days to Cover | 31.72 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Reneo Pharmaceuticals (NASDAQ: RPHM) through any online brokerage.
Other companies in Reneo Pharmaceuticals’s space includes: Kezar Life Sciences (NASDAQ:KZR), Vaxxinity (NASDAQ:VAXX), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Eagle Pharmaceuticals (NASDAQ:EGRX).
The latest price target for Reneo Pharmaceuticals (NASDAQ: RPHM) was reported by HC Wainwright & Co. on Friday, December 15, 2023. The analyst firm set a price target for 1.50 expecting RPHM to fall to within 12 months (a possible -14.77% downside). 9 analyst firms have reported ratings in the last year.
The stock price for Reneo Pharmaceuticals (NASDAQ: RPHM) is $1.76 last updated Today at April 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Reneo Pharmaceuticals.
Reneo Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Reneo Pharmaceuticals.
Reneo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.